lonidamine has been researched along with Carcinoma, Small Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biglietto, M; Carteni, G; De Cesare, M; Pacilio, G | 1 |
| Kimura, I; Kiura, K; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
| Band, P; Murray, N; Shah, A | 1 |
1 trial(s) available for lonidamine and Carcinoma, Small Cell
| Article | Year |
|---|---|
Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Muscles; Pyrazoles; Random Allocation | 1984 |
2 other study(ies) available for lonidamine and Carcinoma, Small Cell
| Article | Year |
|---|---|
An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Indazoles; Lung Neoplasms; Tumor Cells, Cultured | 1992 |
Phase II study of lonidamine in patients with small cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Pyrazoles | 1987 |